Bright Minds Biosciences Inc. (DRUG)
Nasdaq: DRUG · Pharmaceutical Preparations · New York, NY · filing with the SEC since 2020
Filings
176 filings since 2017 beside 4 insider forms · and emerging growth company · read from EDGAR on Nov 13, 2026Due next and emerging growth company
40-F
Annual report, Canadian filer for the fiscal year ending Sep 30, 2026Foreign filers have four months after the fiscal year ends.
by Jan 28, 2027
A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files.
Filings a yearinsider forms included
4272618323934
2026 counts to Nov 13, 2026.
SEC letters: 4 in the last 36 months, the newest Aug 28, 2025.
Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.
FiledFormWhat it is, in plain wordsPeriodAsk
40 of 176 shown
Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.